RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

• Status: Terminated
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine if the administration of a mix of Sufentanil and Morphine in intrathecal is a better analgesia regimen than PCA alone in patient post-VATS.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Université de Sherbrooke
• Treatments: Morphine; Sufentanil

Criteria

Inclusion Criteria:

• VATS

• ASA 1,2 or 3

• Minimum weight of 50 kg

• Patient able to consent

Exclusion Criteria:

• Patient refusal

• Patient unable to understand PCA

• Contraindication to rachianalgesia

• Zona

• Pregnancy

• Over 30 mg of morphine during the last 24 hours

• Use of Pregabalin, Gabapentin, Doluxetin, Amitriptyline or NSAI in a context of chronic pain

• Severe allergic reaction to morphine, hydromorphone, sufentanil or local anesthetic

• Intubation over 1 hour after surgery (unability to use PCA)

• High risk of conversion to thoracotomy

• Unable to perform rachianalgesia due to technical difficulties